US2019100780A1PendingUtilityA1

Tailored oils produced from recombinant oleaginous microorganisms

73
Assignee: CORBION BIOTECH INCPriority: Feb 2, 2011Filed: Sep 7, 2018Published: Apr 4, 2019
Est. expiryFeb 2, 2031(~4.6 yrs left)· nominal 20-yr term from priority
C07C 69/52A23L 33/115C12P 7/6463C12N 9/0071C12N 15/79C10L 2290/26C10L 1/02C12N 9/1029C12N 15/52C12N 9/16C10L 2200/0476A23V 2002/00C10L 2290/30Y02E50/13Y02E50/10
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions for the production of oil, fuels, oleochemicals, and other compounds in recombinant microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a lipase, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a keto acyl-ACP synthase enzyme, a fatty acyl-ACP thioesterase, a fatty acyl-CoA/aldehyde reductase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, a fatty acid hydroxylase, a desaturase enzyme, a fatty aldehyde decarbonylase, and/or an acyl carrier protein are useful in manufacturing transportation fuels such as renewable diesel, biodiesel, and renewable jet fuel, as well as oleochemicals such as functional fluids, surfactants, soaps and lubricants.

Claims

exact text as granted — not AI-modified
1 .- 114 . (canceled) 
     
     
         115 . A method of producing a triglyceride oil, the method comprising:
 a. cultivating a recombinant oleaginous microbe, the microbe comprising an exogenous gene that encode a β-ketoacyl synthase II (KASII) peptide;   b. recovering the triglyceride oil from said recombinant oleaginous microbe; and   wherein the triglyceride oil is enriched in C18 fatty acids or reduced in C16 fatty acids.   
     
     
         116 . The method of  claim 115 , wherein the triglyceride oil is enriched in C18:0 and C18:1 fatty acids. 
     
     
         117 . The method of  claim 115 , wherein the triglyceride is reduced in C16:0 fatty acids. 
     
     
         118 . The method of  claim 115 , wherein the triglyceride oil comprises at least 60% C18:1. 
     
     
         119 . The method of  claim 115 , wherein the recombinant oleaginous microbe is microalgae. 
     
     
         120 . The method of  claim 119 , wherein the microalgae is the genus  Prototheca  or  Chlorella.    
     
     
         121 . The method of  claim 120 , wherein the microalgae is  Prototheca moriformis.    
     
     
         122 . The method of  claim 119 , wherein the exogenous nucleic acids are codon-optimized for expression in microalgae. 
     
     
         123 . The method of  claim 122 , wherein the codon optimized nucleic acids contains the most or second most preferred codon of Table 2 for at least 60% of the codons of the coding sequence. 
     
     
         124 . The method of  claim 115 , wherein the recombinant oleaginous microbe comprises a second exogenous gene, wherein the second exogenous encodes a sucrose invertase. 
     
     
         125 . A triglyceride oil produced by the method of  claim 115 . 
     
     
         126 . A recombinant oleaginous microbial cell, the recombinant microbial cell comprising an exogenous gene that encodes a β-ketoacyl synthase II (KASII) peptide, wherein fatty acids of triglyceride oil produced by the recombinant microbial cell is enriched in C18 fatty acids or reduced in C16 fatty acids. 
     
     
         127 . The recombinant oleaginous microbial cell of  claim 126 , wherein the triglyceride oil is enriched in C18:0 and C18:1 fatty acids. 
     
     
         128 . The recombinant oleaginous microbial cell of  claim 127 , wherein the triglyceride oil comprises at least 60% C18:1. 
     
     
         129 . The recombinant oleaginous microbial cell of  claim 126 , wherein the recombinant oleaginous microbe is microalgae. 
     
     
         130 . The recombinant oleaginous microbial cell of  claim 129 , wherein the microalgae is the genus  Prototheca  or  Chlorella.    
     
     
         131 . The recombinant oleaginous microbial cell of  claim 130 , wherein the microalgae is  Prototheca moriformis.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.